Moloney Securities Asset Management, LLC Surface Oncology, Inc. Transaction History

Moloney Securities Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.61 - $1.03 $610 - $1,030	-1,000 Reduced 7.55%	12,250 $8,000
Q4 2022 Jan 30, 2023	BUY	$0.62 - $1.21 $8,215 - $16,032	13,250 New	13,250 $10,000
Q1 2021 Apr 28, 2021	SELL	$7.25 - $13.82 $72,500 - $138,200	-10,000 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$6.87 - $10.48 $68,700 - $104,800	10,000 New	10,000 $92,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.